A
Alcista
Alcista · 25%CLOV
$3.66
Precio del escenario
$4.480
-0.191 (-4.27%)Al cierre
Loading chart…
- Máximo
- 4.707
- Apertura
- 4.680
- Precio medio ponderado por volumen
- 4.55
- Volumen
- 3.72M
- Capitalización
- 645.37M
- Mínimo
- 4.460
- Importe
- 16.91M
- EV/EBITDA, TTM
- 16.96
Clover Health Investments, Corp. is a physician enablement technology company. The Company is focused on bringing access to healthcare to everyone on Medicare. This includes a focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is a technology platform that empowers providers to deliver intuitive data-driven, personalized care to help physicians detect, identify, and manage diseases earlier. This physician-enablement platform is designed to synthesize comprehensive, longitudinal sets of data to generate provider-focused machine learning, artificial intelligence and rules-based insights, and to drive action by surfacing the relevant, personalized information about each patient to his or her provider. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states.
Análisis de IA of Clover Health Investments Corp (CLOV)
ComprarClover Health Investments Corp (CLOV) is a good buy right now, with a current price of $4.48 and a forward P/E ratio of 37.74, indicating strong growth potential. The stock has seen a year-to-date change of +85.89%, reflecting significant upward momentum. The main risk is the RSI of 34.94, suggesting the stock is currently oversold, but the positive sentiment from analysts and strong revenue growth supports a bullish outlook.
Métricas de valoración
El PER previsto actual de Clover Health Investments Corp (CLOV) es 37.74, frente a su media de 5 años de 3.53.
Escenarios de precio de Alphio AI para CLOV
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.
Ballenas con CLOV en cartera
Cronología de eventos
Noticias
9.510-09stocktwitsMedicare Star Ratings Shift Impacts Stock Prices
9.509-15stocktwitsAlignment Healthcare Shares Plunge 22% Amidst Overhaul Challenges
9.509-15stocktwitsHumana's 2026 Profit Expected to Drop by $3.5 Billion
6.009-10CNBCLatest Wall Street Ratings Overview
2.008-13NASDAQ.COMClover Health (CLOV) Q2 2026 Earnings Call Transcript
Preguntas frecuentes sobre CLOV, respondidas por Alphio AI
Clover Health Investments, Corp. is a physician enablement technology company. The Company is focused on bringing access to healthcare to everyone on Medicare. This includes a focus on seniors, who have historically lacked access to affordable healthcare. Its software platform, Clover Assistant, is a technology platform that empowers providers to deliver intuitive data-driven, personalized care to help physicians detect, identify, and manage diseases earlier. This physician-enablement platform is designed to synthesize comprehensive, longitudinal sets of data to generate provider-focused machine learning, artificial intelligence and rules-based insights, and to drive action by surfacing the relevant, personalized information about each patient to his or her provider. The Company, through its Insurance segment, provides Preferred Provider Organization (PPO) and Health Maintenance Organization (HMO) plans to Medicare Advantage (MA) members in several states. It operates in the Healthcare sector (HOSPITAL & MEDICAL SERVICE PLANS industry).
Clover Health Investments Corp (CLOV) is a good buy right now, with a current price of $4.48 and a forward P/E ratio of 37.74, indicating strong growth potential. The stock has seen a year-to-date change of +85.89%, reflecting significant upward momentum. The main risk is the RSI of 34.94, suggesting the stock is currently oversold, but the positive sentiment from analysts and strong revenue growth supports a bullish outlook.
Comunidad
Más ↗
HUM Stock Soars, ALHC Sinks As CMS Star Ratings Redraw 2028 Bonuses $HUM $ALHC $CLOV $CVS
Mostrar másEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.